Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/QD6q_44jgnk/226186.php
Monday 23 May 2011
New Study Aims To Improve Long-Term Treatment For Patients With Bipolar Disorder
Patients with bipolar disorder may be eligible for a new clinical research study comparing two medications -- quetiapine (Seroquel), a widely prescribed second-generation antipsychotic mood-stabilizing medication, and lithium, the gold-standard mood stabilizer. NewYork-Presbyterian Hospital/Weill Cornell Medical Center is one of 10 sites nationally -- and the only site in the greater New York metropolitan area -- participating in the CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness) study. The research is funded by a $10 million grant from the U.S...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment